Decreased DAZAP1, an oncogenic signature, was observed in ESCC tumor samples and was correlated with poor survival, and this enhanced the migratory and invasive capacities in ESCC cell lines [74]. The gene discussed is DAZAP1; the disease is esophageal squamous cell carcinoma.